Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
04/2010
04/20/2010US7700597 For treating diseases or conditions mediated by cannabinoid receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (smoking cessation), gastrointestinal disorders, and cardiovascular conditions
04/20/2010US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
04/20/2010US7700522 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/20/2010CA2319680C Compounds and compositions for delivering active agents
04/20/2010CA2279331C Compounds and compositions for delivering active agents
04/15/2010WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
04/15/2010WO2010042482A1 Compositions and methods for inhibiting the agglomeration of hydrates
04/15/2010WO2010042168A2 Methods for making ethanolamine(s) and ethyleneamine(s) from ethylene oxide and ammonia, and related methods
04/15/2010US20100094008 Methods of making cyclic, n-amino functional triamines
04/15/2010US20100094007 Methods of making cyclic, N-amino functional triamines
04/15/2010US20100094006 Novel pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof
04/15/2010US20100094002 Thiazole Compound and Use Thereof
04/15/2010US20100093743 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
04/15/2010US20100093707 Acid amide derivatives, process for their production and pesticides containing them
04/15/2010CA2738667A1 Compositions and methods for inhibiting the agglomeration of hydrates
04/14/2010EP2174934A1 Oxopyrazine derivative and herbicide
04/14/2010EP2173725A2 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
04/14/2010EP2173717A2 Novel glucokinase activators and methods of using same
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1477482B1 Novel phenylalanine derivative
04/14/2010CN101693697A Pyrizdazine derivatives and their use as therapeutic agents
04/14/2010CN101693696A Acyl thiourea compound containing pyrazinyl hydrazine and preparation method and application thereof
04/13/2010US7696348 N,N',N'-triphenyl-N-[4-(3-phenylquinoxalin-2-yl)phenyl]benzene-1,4-diamine; bipolar, thermostability; light emiiting diodes with low driving voltage and low power consumption and high luminous efficiency
04/13/2010US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
04/13/2010CA2425440C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/08/2010WO2010039957A1 Tryptophan hydroxylase inhibitors and methods of their use
04/08/2010WO2010037190A1 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol
04/08/2010WO2010007248A3 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
04/08/2010WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists
04/08/2010US20100087643 Method for producing optically active 2-arylpiperazine derivative
04/08/2010US20100087642 Catalysis of Diketopiperazine Synthesis
04/08/2010US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
04/08/2010US20100087457 Dosages and methods for the treatment of cancer
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2010US20100087440 Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use
04/08/2010US20100087437 Novel Potassium Channel Blockers
04/08/2010US20100087396 Novel Compounds Having Selective Inhibiting Effect at GSK3
04/08/2010US20100087339 Compositions and methods for inhibiting the agglomeration of hydrates in a process
04/08/2010US20100087338 Compositions and methods for inhibiting the agglomeration of hydrates
04/08/2010US20100086609 Methods and Compositions for Delivering Peptides
04/08/2010US20100084611 Corrosion inhibitors for an aqueous medium
04/08/2010CA2739263A1 Tryptophan hydroxylase inhibitors and methods of their use
04/08/2010CA2738694A1 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol
04/07/2010EP2170848A1 Pyrazinone derivatives and their use in the treatment of lung diseases
04/07/2010EP2170847A2 Substituted piperazines as cb1 antagonists
04/07/2010EP2170846A2 Substituted piperazines as cb1 antagonists
04/07/2010EP1971581B1 Piperazine compounds with a herbicidal action
04/07/2010EP1786785B1 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
04/06/2010US7692011 8-hydroxy and 8-mercapto quinazolinones
04/06/2010US7691904 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation as well as treating cancer, nervous system disorders and respiratory system disorders,
04/06/2010US7691858 3-(2,4-Diaminopteridin-6-yl)phenol or 6-(1H-Indol-4-yl)pteridine-2,4-diamine;phosphoinositide 3-kinase; enzyme inhibitors; vasculostatic agents; antiinflammatory agents; antiarthric agents; transplant rejecction; autoimmune diseases; anticarcinogenic agents
04/06/2010US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2449899C Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
04/01/2010WO2010034212A1 Phenoxy acetic acid pyrazine ester derivatives, the preparation methods and uses thereof
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
03/2010
03/31/2010EP2168576A2 New utilities of tricyclic compounds
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/31/2010CN101687870A Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
03/31/2010CN101687040A Integrated photoactive small molecules and uses thereof
03/31/2010CN101684102A Phenoxyacetic acid ester pyrazine derivative as well as preparation method and applications thereof
03/31/2010CN101684101A Piperazinone substituted tetracycline derivatives
03/31/2010CN101684100A Preparation method of dexrazoxane and pharmaceutical salts thereof
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075977 Beta-3 receptor ligands and their use in therapy
03/25/2010US20100075974 Heterocyclic gpr40 modulators
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075924 Dutpase inhibitors
03/25/2010CA2737738A1 Heterocyclic carboxamide compounds
03/24/2010EP2166000A1 7-, 8- and 9-substituted tetracycline compounds
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010CN101679400A Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
03/24/2010CN101679370A Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
03/24/2010CN101679317A Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid r
03/24/2010CN101679316A Piperazine compounds with a herbicidal action
03/24/2010CN101679315A Novel piperazine salts as d3/d2 antagonists
03/24/2010CN101679261A Piperazine and piperidine mglur5 potentiators
03/24/2010CN101678020A Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/23/2010US7683097 Topoisomerase inhibitors
03/23/2010US7683053 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
03/23/2010US7682444 Azobarbituric mono-cation salt and azobarbituric di-cation saltis reacted with a nickel compound and melamine; metallization, complexing; photoresists, color filters, liquidcrystal displays, ink jet printers
03/18/2010WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods
03/18/2010WO2010029986A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/18/2010US20100069638 Sulfonamide derivative having pgd2 receptor antagonistic activity
03/18/2010US20100069636 Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which Have the Same
03/18/2010US20100069388 N-hydroxyacrylamide compounds
03/18/2010US20100069370 Compounds, compositions and methods
03/18/2010US20100068272 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
03/18/2010US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them
03/18/2010CA2735417A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivatives containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/17/2010EP1284966B1 Process for the synthesis of amine ethers from secondary amino oxides
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678785 Fungicides; (E)-N-[2-((S)-3-Aminopyrrolidin-1-yl)-2-oxo-ethyl]-3-phenyl-N-(3'-trifluoromethoxy-biphenyl-4-yl)-acrylamide; inhibitors of beta -1,3-glucan synthase; readily synthesised by standard chemistry, and have more drug-like properties that are compatible with oral bioavailability
03/16/2010CA2500492C Aryl sulfonamides
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 187